Jeffery S Rubin

Title: Jeffery S Rubin: Innovator in Hepatic Growth Factor Research

Introduction

Jeffery S Rubin is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical research, particularly in the area of hepatic growth factors. His work has implications for understanding and diagnosing various proliferative disorders.

Latest Patents

Rubin holds a patent titled "Hepatic growth factor receptor is the MET proto-oncogene." This invention relates to a complex comprising hepatocyte growth factor (HGF) and the met proto-oncogene protein. The patent also details methods for detecting the presence of HGF ligand and the met proto-oncogene receptor. Furthermore, it outlines methods for isolating either the ligand or receptor, or a complex comprising both. This invention is particularly relevant for diagnosing proliferative disorders and diseases such as hepatitis or hepatocarcinogenesis by detecting these ligand-receptor pairs. He has 1 patent to his name.

Career Highlights

Rubin's career has been marked by his dedication to advancing medical science. He works for the United States of America as represented by the Department of Health, where he continues to contribute to important research initiatives. His work has the potential to impact the diagnosis and treatment of serious health conditions.

Collaborations

Throughout his career, Rubin has collaborated with esteemed colleagues, including Donald P Bottaro and Donna Faletto. These partnerships have enhanced the scope and impact of his research.

Conclusion

Jeffery S Rubin is a prominent figure in the field of hepatic growth factor research, with a focus on innovative diagnostic methods. His contributions are vital for advancing our understanding of proliferative disorders and improving patient outcomes.